Time-lapse intravital imaging studies in mouse models of anti-PD-1 responsive cancers, have shown that macrophages uptake anti-PD-1 mAbs from the surface of T cells [99], reducing their efficacy, an unhelpful consequence of mAbs binding the high affinity FcRs on these macrophages. Here, PDCD1 is linked to cancer.